Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Global X Genomics & Biotechnology ETF (NQ:GNOM)

47.37 -0.44 (-0.92%)
Streaming Delayed Price Updated: 11:29 AM EST, Feb 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Global X Genomics & Biotechnology ETF

News headline image
Moderna Stock Gains After FDA Accepts Company’s Revised Flu Vaccine Application For Review ↗
The FDA has now accepted the biologics license application for review, setting a Prescription Drug User Fee Act goal date of Aug. 5, 2026. 
Via Stocktwits
News headline image
Qiagen Shares Rise Premarket As Preliminary Q1 Results, Hikes FY25 EPS Guidance ↗
Qiagen (QGEN) shares up premarket after disclosing strong preliminary Q1 2025 results and raising full-year EPS outlook. Stock price up 3.06%. 
Via Benzinga
News headline image
3 Gene Editing Stocks with Potential to Transform Medicine ↗
Gene-editing holds substantial promise for treating thousands of diseases – creating incredible opportunities for gene editing stocks. 
Via InvestorPlace
News headline image
The 3 Best Gene Editing Stocks to Buy in July 2024 ↗
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks. 
Via InvestorPlace
News headline image
ETF Battles ARKG Vs. GNOM - What's The Better Genomic/Biotech Play? ↗
Each ETF is judged against the other in key categories like cost, exposure strategy, performance, and a mystery category. 
Via Talk Markets
News headline image
Genomics Game-Changers: 3 Stocks Unlocking the Secrets of Life ↗
Genomics is the future of medicine, creating big opportunity for some of the top genomics stock picks to buy today. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks with the Potential to Make You an Overnight Millionaire ↗
Pay close attention to gene editing stocks. By 2028, according to MarketsandMarkets, the market could be worth about $10.6 billion. 
Via InvestorPlace
News headline image
3 Stocks That Could Be the Next Big Thing in Gene Editing ↗
Gene editing could revolutionize how millions of patients are treated. That could create big opportunities for gene-editing stocks. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks With Unprecedented Surge Potential ↗
While CRISPR will certainly be exciting to watch, here are some other gene-editing stocks with unprecedented surge potential. 
Via InvestorPlace
News headline image
3 Once-in-a-Lifetime Gene Editing Stocks with Unprecedented Surge Potential ↗
Some of the top gene-editing stocks have had immense surge potential. Look at CRISPR Therapeutics, for example. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks to Generate Super-Charged Gains ↗
As things progress, such techniques may be able to knock out every disease known, creating massive opportunity for gene-editing stocks. 
Via InvestorPlace
News headline image
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket ↗
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it. 
Via InvestorPlace
News headline image
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy. 
Via InvestorPlace
News headline image
3 Gene Editing Stocks With the Best Long-Term Potential ↗
These gene editing stocks are likely to deliver massive gains ahead in the fast-evolving biotech space 
Via InvestorPlace
News headline image
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years ↗
CRISPR could be revolutionary, leading us to put together this list of CRISPR stocks that will make you rich in 10 years. 
Via InvestorPlace
News headline image
ETF Battles: Finding the Top Genomics Biotech ETF – A Triple Header of ARKG vs IDNA vs GNOM ↗
The search for therapies tackling chronic illnesses like cancer, diabetes, and heart disease has put stocks in the biotechnology and genomics industry sector on center stage. 
Via Talk Markets
News headline image
A Comprehensive Guide To Genomic ETFs ↗
Given the growing applications of gene-editing, it is a rising market which offers endless opportunities. Growing demand for personalized medicine, solid investments and higher R&D activities will soon... 
Via Talk Markets
News headline image
Top-Performing Biotech ETFs of Last Week ↗
Investors may want to tap the bullishness in the biotech sector with the best biotech ETFs of last week. 
Via Talk Markets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.